468074292	468074292	CD	B-NP	O
|	|	NN	I-NP	O
THO	THO	NN	I-NP	O
|	|	NN	I-NP	O
20694051	20694051	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
6613533	6613533	CD	B-NP	O
|	|	CC	I-NP	O
1/21/2006	1/21/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Change	Change	NNP	I-NP	O
in	in	IN	B-PP	O
mental	mental	JJ	B-NP	O
status	status	NN	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
3/26/2006	3/26/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
5/26/2006	5/26/2006	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NN	I-NP	O
******	******	SYM	B-VP	O
ALEQUIN	ALEQUIN	NN	B-NP	O
,	,	,	O	O
GARLAND	GARLAND	NN	B-NP	O
071-05-26-6	071-05-26-6	CD	I-NP	O
Troit	Troit	NNP	I-NP	O
West	West	NNP	I-NP	O
Ville	Ville	NNP	I-NP	O
,	,	,	O	O
North	North	NNP	B-NP	O
Carolina	Carolina	NNP	I-NP	O
93245	93245	CD	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
10/28/06	10/28/06	CD	B-NP	O
AT	AT	NN	I-NP	O
02	02	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
WIXSON	WIXSON	NNP	B-NP	O
,	,	,	O	O
MATT	MATT	NNP	B-NP	O
SAMMIE	SAMMIE	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.P.H.	M.P.H.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Skilled	Skille	VBN	B-VP	O
Nursing	Nurse	VBG	B-VP	O
Facility	Facility	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
VITAMIN	VITAMIN	NNP	B-NP	O
C	C	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ASCORBIC	ASCORBIC	NNP	I-NP	O
ACID	ACID	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
500	500	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
CIPROFLOXACIN	CIPROFLOXACIN	NN	I-NP	O
400	400	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
Q12H	Q12H	NN	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
11/17	11/17	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
Please	Please	NN	B-NP	B-protein
take	take	VB	B-VP	O
until	until	IN	B-PP	O
7/21/06	7/21/06	CD	B-NP	O
.	.	.	O	O

Number	Number	NN	B-NP	O
of	of	IN	B-PP	O
Doses	Dose	NNS	B-NP	O
Required	Require	VBN	B-VP	O
-LRB-	-LRB-	HYPH	B-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
FOLATE	FOLATE	JJ	I-NP	O
-LRB-	-LRB-	NN	I-NP	B-protein
FOLIC	FOLIC	NN	I-NP	I-protein
ACID	ACID	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	I-protein
1	1	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
DAILY	DAILY	NN	I-NP	I-protein
LASIX	LASIX	NN	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
40	40	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
DAILY	DAILY	NNP	I-NP	I-protein
LACTULOSE	LACTULOSE	NNP	I-NP	I-protein
30	30	CD	I-NP	I-protein
MILLILITERS	MILLILITERS	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QID	QID	NNP	I-NP	I-protein
Starting	Starting	NNP	I-NP	I-protein
Today	Today	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
11/17	11/17	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
please	please	VB	B-VP	O
do	do	VBP	B-VP	O
not	not	RB	I-VP	O
skip	skip	VB	I-VP	O
doses	dose	NNS	B-NP	O
even	even	RB	B-SBAR	O
if	if	IN	I-SBAR	O
many	many	JJ	B-NP	O
loose	loose	JJ	I-NP	O
stools	stool	NNS	I-NP	O
.	.	.	O	O

FLAGYL	FLAGYL	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
METRONIDAZOLE	METRONIDAZOLE	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	I-protein
500	500	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
Q8H	Q8H	NN	I-NP	I-protein
Starting	Starting	NNP	I-NP	I-protein
Today	Today	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
11/17	11/17	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
Stop	Stop	NNP	B-NP	O
taking	take	VBG	B-VP	O
on	on	IN	B-PP	O
7/21/06	7/21/06	CD	B-NP	O
.	.	.	O	O

ALDACTONE	ALDACTONE	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
SPIRONOLACTONE	SPIRONOLACTONE	NN	I-NP	O
-RRB-	-RRB-	HYPH	O	O
75	75	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Give	Give	NNP	I-NP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
3/12/06	3/12/06	CD	B-NP	O
by	by	IN	B-PP	O
STARZYNSKI	STARZYNSKI	NN	B-NP	O
,	,	,	O	O
DANIEL	DANIEL	NNP	B-NP	O
O.	O.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
KCL	KCL	NN	B-NP	O
IV	IV	CD	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
805776770	805776770	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SPIRONOLACTONE	SPIRONOLACTONE	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
monitoring	monitor	VBG	B-VP	O
THIAMINE	THIAMINE	NN	B-NP	B-protein
HCL	HCL	NN	I-NP	I-protein
100	100	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
DAILY	DAILY	NNP	I-NP	O
MULTIVITAMIN	MULTIVITAMIN	NNP	I-NP	O
THERAPEUTIC	THERAPEUTIC	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
THERAPEUTIC	THERAPEUTIC	NNP	I-NP	O
MULTIVI	MULTIVI	NNP	I-NP	O
...	...	:	O	O
-RRB-	-RRB-	SYM	B-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	O
PO	PO	NN	I-NP	O
DAILY	DAILY	NN	I-NP	O
MSIR	MSIR	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
MORPHINE	MORPHINE	NNP	I-NP	O
IMMEDIATE	IMMEDIATE	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
7.5	7.5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
Q4H	Q4H	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Pain	Pain	NNP	I-NP	O
FLOVENT	FLOVENT	NNP	I-NP	O
HFA	HFA	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FLUTICASONE	FLUTICASONE	NNP	I-NP	O
PROPIONATE	PROPIONATE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	B-protein
220	220	CD	I-NP	I-protein
MCG	MCG	NNP	I-NP	I-protein
INH	INH	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	I-protein
CELEXA	CELEXA	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
CITALOPRAM	CITALOPRAM	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
20	20	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
DAILY	DAILY	NNP	I-NP	I-protein
CELECOXIB	CELECOXIB	NNP	I-NP	I-protein
100	100	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
DAILY	DAILY	NNP	I-NP	I-protein
Starting	Starting	NNP	I-NP	I-protein
Today	Today	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
11/17	11/17	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
PRN	PRN	NNP	I-NP	I-protein
Pain	Pain	NNP	I-NP	I-protein
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
Please	Please	NN	B-NP	B-protein
do	do	VBP	B-VP	O
not	not	RB	I-VP	O
increasing	increase	VBG	I-VP	O
dosing	dosing	NN	B-NP	O
to	to	TO	B-PP	O
BID	BID	NN	B-NP	O
,	,	,	O	O
given	give	VBN	B-PP	O
risk	risk	NN	B-NP	O
of	of	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	O
side	side	NN	I-NP	O
effects	effect	NNS	I-NP	O
.	.	.	O	O

Food/Drug	Food/Drug	NN	B-NP	O
Interaction	Interaction	NN	I-NP	O
Instruction	Instruction	NN	I-NP	O
Take	Take	NN	I-NP	O
with	with	IN	B-PP	O
food	food	NN	B-NP	O
KEPPRA	KEPPRA	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
LEVETIRACETAM	LEVETIRACETAM	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
CALTRATE	CALTRATE	NNP	I-NP	O
600	600	CD	I-NP	O
+	+	SYM	I-NP	O
D	D	NN	I-NP	O
-LRB-	-LRB-	SYM	O	O
CALCIUM	CALCIUM	NN	B-NP	O
CARBONATE	CARBONATE	NN	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
500	500	CD	I-NP	O
MG	MG	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
...	...	:	O	O
-RRB-	-RRB-	SYM	B-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	O
PO	PO	NN	I-NP	O
BID	BID	NN	I-NP	O
LIDODERM	LIDODERM	NN	I-NP	O
5	5	CD	B-NP	O
%	%	NN	I-NP	O
PATCH	PATCH	NN	I-NP	O
-LRB-	-LRB-	SYM	B-NP	O
LIDOCAINE	LIDOCAINE	NN	I-NP	O
5	5	CD	B-NP	O
%	%	NN	I-NP	O
PATCH	PATCH	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
TOPICAL	TOPICAL	NN	I-NP	O
TP	TP	NN	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
11/17	11/17	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
one	one	CD	B-NP	O
to	to	TO	B-PP	O
lumbar	lumbar	JJ	B-NP	O
area	area	NN	I-NP	O
.	.	.	O	O

apply	apply	RB	B-ADVP	O
for	for	IN	B-PP	O
12	12	CD	B-NP	O
hr	hr	NN	I-NP	O
and	and	CC	O	O
remove	remove	VB	B-VP	O
for	for	IN	B-PP	O
12	12	CD	B-NP	O
hr	hr	NN	I-NP	O
.	.	.	O	O

NOVOLOG	NOVOLOG	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
ASPART	ASPART	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Sliding	Sliding	NNP	I-NP	O
Scale	Scale	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
subcutaneously	subcutaneously	RB	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
SC	SC	NN	I-NP	B-protein
AC	AC	NN	I-NP	I-protein
If	If	IN	B-SBAR	I-protein
BS	BS	NNP	B-NP	I-protein
is	be	VBZ	B-VP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
125	125	CD	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
0	0	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
125-150	125-150	CD	B-NP	O
,	,	,	O	O
then	then	RB	O	O
give	give	VB	B-VP	O
2	2	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
151-200	151-200	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
3	3	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
201-250	201-250	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
4	4	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
251-300	251-300	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
6	6	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
301-350	301-350	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
8	8	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
351-400	351-400	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
10	10	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
and	and	CC	O	O
call	call	VB	B-VP	O
HO	HO	NN	B-NP	B-protein
Call	Call	NN	I-NP	I-protein
HO	HO	NN	I-NP	I-protein
if	if	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
400	400	CD	B-NP	O
MAALOX-TABLETS	MAALOX-TABLETS	NNP	I-NP	O
QUICK	QUICK	NNP	I-NP	O
DISSOLVE/CHEWABLE	DISSOLVE/CHEWABLE	NNP	I-NP	O
1-2	1-2	NN	I-NP	O
TAB	TAB	NNP	I-NP	O
PO	PO	NNP	I-NP	O
Q6H	Q6H	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Upset	Upset	NNP	I-NP	O
Stomach	Stomach	NNP	I-NP	O
VITAMIN	VITAMIN	NNP	I-NP	O
K	K	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
PHYTONADIONE	PHYTONADIONE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
5	5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
PROTONIX	PROTONIX	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
PANTOPRAZOLE	PANTOPRAZOLE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
TOPROL	TOPROL	NNP	I-NP	O
XL	XL	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
METOPROLOL	METOPROLOL	NNP	I-NP	O
SUCCINATE	SUCCINATE	NNP	I-NP	O
EXTENDED	EXTENDED	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
50	50	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

MAGNESIUM	MAGNESIUM	NN	B-NP	B-protein
OXIDE	OXIDE	NN	I-NP	I-protein
420	420	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	O
DIET	DIET	NNP	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	B-protein
2	2	CD	I-NP	I-protein
gm	gm	NN	I-NP	I-protein
Na	Na	NN	I-NP	I-protein
/	/	SYM	B-NP	I-protein
low	low	JJ	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	O
I	I	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FDI	FDI	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
DIET	DIET	NNP	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
gram	gram	NN	I-NP	O
Sodium	Sodium	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Resume	Resume	VB	B-VP	O
regular	regular	JJ	B-NP	O
exercise	exercise	NN	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr	Dr	NNP	B-NP	O
Gillogly	Gillogly	NNP	I-NP	O
rheumatology	rheumatology	NN	I-NP	O
-	-	HYPH	B-NP	O
arthritis	arthritis	NN	I-NP	O
center	center	NN	I-NP	O
180-430-4095	180-430-4095	CD	I-NP	O
10/25	10/25	CD	I-NP	O
@	@	NN	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
30	30	CD	B-NP	O
pm	pm	NN	I-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
Dr	Dr	NNP	B-NP	O
Mikos	Mikos	NNP	I-NP	O
IMC	IMC	NNP	I-NP	O
3/17	3/17	CD	I-NP	O
@	@	NN	I-NP	O
2	2	CD	I-NP	O
:	:	:	O	O
30	30	CD	B-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Cramblit	Cramblit	NNP	I-NP	O
-	-	HYPH	B-NP	O
please	please	NN	I-NP	O
call	call	NN	I-NP	O
for	for	IN	B-PP	O
appointment	appointment	NN	B-NP	O
Next	Next	JJ	I-NP	O
available	available	JJ	B-ADJP	O
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
HALOPERIDOL	HALOPERIDOL	NN	B-NP	O
,	,	,	O	O
LORAZEPAM	LORAZEPAM	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
Change	Change	NN	B-NP	O
in	in	IN	B-PP	O
mental	mental	JJ	B-NP	O
status	status	NN	I-NP	O
PRINCIPAL	PRINCIPAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Change	Change	NNP	I-NP	O
in	in	IN	B-PP	O
mental	mental	JJ	B-NP	O
status	status	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
s/p	s/p	NN	I-NP	O
gi	gi	NN	I-NP	O
bleed	bleed	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
S/P	S/P	NN	I-NP	O
upper	upper	JJ	I-NP	O
GI	GI	NN	I-NP	O
bleeding	bleed	VBG	B-VP	O
-RRB-	-RRB-	NN	B-NP	O
EtOH	EtOH	NN	I-NP	O
abuse	abuse	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
alcohol	alcohol	NN	I-NP	O
abuse	abuse	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
coagulopathy	coagulopathy	NN	I-NP	O
cirrhosis	cirrhosis	NN	I-NP	O
,	,	,	O	O
hepatic	hepatic	JJ	B-NP	B-protein
encephalopathy	encephalopathy	NN	I-NP	I-protein
COPD	COPD	NN	I-NP	I-protein
-LRB-	-LRB-	HYPH	B-NP	I-protein
chronic	chronic	JJ	I-NP	O
obstructive	obstructive	JJ	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
fracture	fracture	NN	I-NP	O
of	of	IN	B-PP	O
left	left	JJ	B-NP	O
hand	hand	NN	I-NP	O
-	-	HYPH	B-NP	O
2nd/3rd	2nd/3rd	VBN	I-NP	O
metacarpals	metacarpal	NNS	I-NP	O
,	,	,	O	O
4th/5th	4th/5th	JJ	B-NP	O
proximal	proximal	JJ	I-NP	O
phalanges	phalange	NNS	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
OTHER	OTHER	NNP	B-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Chest	Chest	NNP	I-NP	O
x-ray	x-ray	NN	I-NP	O
,	,	,	O	O
head	head	NN	B-NP	O
CT	CT	NN	I-NP	O
,	,	,	O	O
right	right	JJ	B-NP	O
upper	upper	JJ	I-NP	O
quadrant	quadrant	JJ	I-NP	O
ultrasound	ultrasound	NN	I-NP	O
,	,	,	O	O
right	right	RB	B-ADVP	O
lower	low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
ultrasound	ultrasound	NN	I-NP	O
.	.	.	O	O

BRIEF	BRIEF	NN	B-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
CC	CC	NN	B-NP	O
:	:	:	O	O
Change	Change	NN	B-NP	O
in	in	IN	B-PP	O
mental	mental	JJ	B-NP	O
status	status	NN	I-NP	O
--	--	:	O	O
--	--	:	O	O
-	-	HYPH	B-NP	O
HPI	HPI	NN	I-NP	O
:	:	:	O	O
57	57	CD	B-NP	O
yo	yo	NN	I-NP	O
F	F	NN	I-NP	O
with	with	IN	B-PP	O
complex	complex	JJ	B-NP	O
PMH	PMH	NN	I-NP	O
including	include	VBG	B-PP	O
squamous	squamous	JJ	B-NP	O
cell	cell	NN	I-NP	O
lung	lung	NN	I-NP	O
cancer	cancer	NN	I-NP	O
s/p	s/p	NN	I-NP	O
RML	RML	NN	I-NP	O
lobectomy	lobectomy	NN	I-NP	O
9/22	9/22	CD	I-NP	O
Has	Has	NNP	I-NP	O
h/o	h/o	NN	I-NP	O
cirrhosis	cirrhosis	NN	I-NP	O
and	and	CC	O	O
hepatic	hepatic	JJ	B-NP	O
encephalopathy	encephalopathy	NN	I-NP	O
.	.	.	O	O

Came	Came	NN	B-NP	O
to	to	TO	B-PP	O
ED	ED	NN	B-NP	O
obtunded	obtund	VBN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
no	no	DT	B-NP	O
spontaneous	spontaneous	JJ	I-NP	O
conversation	conversation	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
with	with	IN	B-PP	O
decreased	decrease	VBN	B-NP	O
BP	BP	NN	I-NP	O
.	.	.	O	O

Reportedly	Reportedly	RB	B-ADVP	O
received	receive	VBN	B-VP	O
all	all	DT	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
medications	medication	NNS	I-NP	O
as	as	IN	B-SBAR	O
prescribed	prescribe	VBN	B-VP	O
in	in	IN	B-PP	O
morning	morning	NN	B-NP	O
at	at	IN	B-PP	O
her	her	PRP$	B-NP	O
nursing	nursing	NN	I-NP	O
home	home	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
ED	ED	NNP	B-NP	O
,	,	,	O	O
received	receive	VBD	B-VP	O
thiamine	thiamine	NN	B-NP	O
and	and	CC	I-NP	O
narcan	narcan	NN	I-NP	O
.	.	.	O	O

Became	Become	VBD	B-VP	O
more	more	RBR	B-ADJP	O
responsive	responsive	JJ	I-ADJP	O
and	and	CC	I-ADJP	O
uncomfortable	uncomfortable	JJ	I-ADJP	O
after	after	IN	B-PP	O
narcan	narcan	NN	B-NP	O
.	.	.	O	O

Ammonia	Ammonia	NNP	B-NP	O
level	level	NN	I-NP	O
elevated	elevate	VBD	B-VP	O
at	at	IN	B-PP	O
233	233	CD	B-NP	O
.	.	.	O	O

--	--	:	O	O
--	--	:	O	O
-	-	:	O	O
PMH	PMH	NN	B-NP	O
:	:	:	O	O
+	+	SYM	B-NP	O
+	+	SYM	O	O
Lung	Lung	NN	B-NP	O
cancer	cancer	NN	I-NP	O
-	-	HYPH	B-NP	O
squamous	squamous	JJ	I-NP	O
cell	cell	NN	I-NP	O
,	,	,	O	O
s/p	s/p	NN	B-NP	O
RML	RML	NN	I-NP	O
lobectomy	lobectomy	NN	I-NP	O
and	and	CC	O	O
RUL	RUL	NN	B-NP	O
wedge	wedge	NN	I-NP	O
resection	resection	NN	I-NP	O
+	+	SYM	B-NP	O
+	+	SYM	B-NP	O
Cirrhosis	Cirrhosis	NN	I-NP	O
-	-	HYPH	B-NP	O
alcoholic	alcoholic	JJ	I-NP	O
and	and	CC	I-NP	O
hep	hep	NN	I-NP	O
C	C	NN	I-NP	O
virus	virus	NN	I-NP	O
,	,	,	O	O
h/o	h/o	VBP	B-VP	O
esophageal	esophageal	JJ	B-NP	O
varices	varix	NNS	I-NP	O
and	and	CC	O	O
GI	GI	NN	B-NP	O
bleed	bleed	NN	I-NP	O
.	.	.	O	O

+	+	SYM	O	O
+	+	SYM	B-NP	O
COPD	COPD	NN	I-NP	O
-	-	HYPH	B-VP	O
not	not	RB	O	O
on	on	IN	B-PP	O
home	home	NN	B-NP	O
oxygen	oxygen	NN	I-NP	O
+	+	SYM	B-NP	O
+	+	SYM	B-NP	O
HTN	HTN	NN	I-NP	B-protein
+	+	SYM	B-NP	O
+	+	SYM	B-NP	O
PVD	PVD	NN	I-NP	O
+	+	SYM	O	O
+	+	SYM	O	O
Seizure	Seizure	NN	B-NP	O
disorder	disorder	NN	I-NP	O
-	-	HYPH	B-ADJP	O
on	on	IN	B-PP	O
Keppra	Keppra	NNP	B-NP	O
+	+	SYM	O	O
+	+	SYM	O	O
h/o	h/o	NN	B-NP	O
SDH	SDH	NN	I-NP	O
-	-	HYPH	B-VP	O
had	have	VBN	B-NP	O
craniotomy	craniotomy	NN	I-NP	O
+	+	SYM	B-NP	O
+	+	SYM	B-VP	O
large	large	JJ	B-NP	O
abdominal	abdominal	JJ	I-NP	O
ventral	ventral	JJ	I-NP	O
hernia	hernia	NN	I-NP	O
+	+	SYM	B-NP	O
+	+	SYM	B-VP	O
chronic	chronic	JJ	B-NP	O
back	back	JJ	I-NP	O
pain	pain	NN	I-NP	O
-	-	HYPH	B-VP	O
known	know	VBN	I-VP	O
spinal	spinal	JJ	B-NP	O
compression	compression	NN	I-NP	O
fractures	fracture	NNS	I-NP	O
at	at	IN	B-PP	O
T8	T8	NN	B-NP	B-DNA
and	and	CC	O	O
bilateral	bilateral	JJ	B-NP	O
sacral	sacral	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
fractures	fracture	NNS	I-NP	O
--	--	:	O	O
--	--	:	O	O
-	-	HYPH	B-NP	O
SHx	SHx	NN	I-NP	O
:	:	:	O	O
Nursing	Nurse	VBG	B-VP	O
home	home	NN	B-NP	O
resident	resident	NN	I-NP	O
for	for	IN	B-PP	O
past	past	JJ	B-NP	O
2	2	CD	I-NP	O
years	year	NNS	I-NP	O
.	.	.	O	O

30	30	CD	B-NP	O
pack-year	pack-year	JJ	I-NP	O
smoking	smoking	NN	I-NP	O
history	history	NN	I-NP	O
.	.	.	O	O

Significant	Significant	JJ	B-NP	O
EtOH	EtOH	NN	I-NP	O
history	history	NN	I-NP	O
.	.	.	O	O

Has	Has	IN	B-PP	O
2	2	CD	B-NP	O
daughters	daughter	NNS	I-NP	O
involved	involve	VBN	B-VP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
care	care	NN	I-NP	O
.	.	.	O	O

--	--	:	O	O
--	--	:	O	O
-	-	:	O	O
FHx	FHx	NN	B-NP	O
:	:	:	O	O
Mother	Mother	NNP	B-NP	O
COPD	COPD	NNP	I-NP	O
,	,	,	O	O
Father	Father	NNP	B-NP	O
prostate	prostate	NN	I-NP	O
cancer	cancer	NN	I-NP	O
/	/	SYM	B-NP	O
CAD	CAD	NN	I-NP	O
.	.	.	O	O

--	--	:	O	O
--	--	:	O	O
-	-	HYPH	B-NP	O
Admit	Admit	NN	I-NP	O
PE	PE	NN	I-NP	O
:	:	:	O	O
T	T	NN	B-NP	O
96.5	96.5	CD	I-NP	O
P	P	NN	I-NP	O
64	64	CD	B-NP	O
BP	BP	NN	I-NP	O
98/53	98/53	CD	B-NP	O
RR	RR	NN	I-NP	O
14	14	CD	B-NP	O
SaO2	SaO2	NN	I-NP	O
93	93	CD	B-NP	O
%	%	NN	I-NP	O
RA	RA	NN	I-NP	O
97	97	CD	B-NP	O
%	%	NN	I-NP	O
3L	3L	NN	I-NP	O
Gen	Gen	NN	I-NP	O
-	-	HYPH	B-NP	O
Awakens	Awaken	NNPS	I-NP	O
briefly	briefly	RB	B-ADVP	O
when	when	WRB	B-ADVP	O
spoken	speak	VBN	B-VP	O
to	to	TO	B-PP	O
.	.	.	O	O

Able	Able	NN	B-NP	O
to	to	TO	B-VP	O
respond	respond	VB	I-VP	O
only	only	RB	B-ADVP	O
with	with	IN	B-PP	O
single	single	JJ	B-NP	O
words	word	NNS	I-NP	O
to	to	TO	B-PP	O
simple	simple	JJ	B-NP	O
questions	question	NNS	I-NP	O
.	.	.	O	O

Appears	Appear	NNS	B-NP	O
sedated	sedate	VBN	B-VP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	B-protein
-	-	HYPH	I-NP	O
PERRL	PERRL	NN	I-NP	B-protein
,	,	,	O	O
scleral	scleral	JJ	B-NP	B-protein
icterus	icterus	NN	I-NP	I-protein
NECK	NECK	NN	I-NP	I-protein
-	-	HYPH	O	O
No	No	DT	B-NP	O
LAN	LAN	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
bruits	bruit	NNS	I-NP	O
,	,	,	O	O
JVP	JVP	NN	B-NP	O
flat	flat	JJ	B-ADJP	O
.	.	.	O	O

CHEST	CHEST	NN	B-NP	O
-	-	HYPH	I-NP	O
Bilateral	Bilateral	JJ	I-NP	O
expiratory	expiratory	JJ	I-NP	O
wheezes	wheeze	NNS	I-NP	O
.	.	.	O	O

HEART	HEART	NN	B-NP	B-protein
-	-	HYPH	I-NP	O
RRR	RRR	NN	I-NP	B-protein
,	,	,	O	O
nl	nl	NN	B-NP	B-protein
S1/S2	S1/S2	NN	I-NP	I-protein
,	,	,	O	O
no	no	DT	B-NP	O
m/r/g	m/r/g	NN	I-NP	O
.	.	.	O	O

ABD	ABD	NN	B-NP	O
-	-	HYPH	B-NP	O
Full-appearing	Full-appearing	JJ	I-NP	O
,	,	,	I-NP	O
large	large	JJ	I-NP	O
ventral	ventral	JJ	I-NP	O
hernia	hernia	NN	I-NP	O
,	,	,	O	O
multiple	multiple	JJ	B-NP	O
scars	scar	NNS	I-NP	O
,	,	,	O	O
soft	soft	JJ	B-NP	O
,	,	,	I-NP	O
non-tender	non-tender	JJ	I-NP	O
,	,	,	I-NP	O
+	+	JJ	I-NP	O
BS	BS	NNP	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
masses	mass	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
HSM	HSM	NN	I-NP	B-protein
.	.	.	O	O

EXT	EXT	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
+	+	SYM	I-NP	O
edema	edema	NN	I-NP	B-protein
bilaterally	bilaterally	RB	B-ADVP	I-protein
-LRB-	-LRB-	SYM	O	I-protein
R	R	NN	B-NP	I-protein
>	>	SYM	B-VP	O
L	L	NN	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

SKIN	SKIN	NN	B-NP	B-protein
-	-	HYPH	O	O
jaundiced	jaundice	VBN	B-VP	O
,	,	,	O	O
palmar	palmar	NN	B-NP	O
erythema	erythema	NN	I-NP	O
,	,	,	O	O
bruises	bruise	VBZ	B-VP	O
spread	spread	VBN	I-VP	O
diffusely	diffusely	RB	B-ADVP	O
.	.	.	O	O

RECTAL	RECTAL	NN	B-NP	O
-	-	HYPH	I-NP	O
Guaiac	Guaiac	NN	I-NP	B-protein
pos	po	NNS	I-NP	I-protein
,	,	,	O	O
light	light	JJ	B-NP	O
brown	brown	JJ	I-NP	O
soft	soft	JJ	I-NP	O
stool	stool	NN	I-NP	O
.	.	.	O	O

NEURO	NEURO	NN	B-NP	B-protein
-	-	HYPH	O	O
Oriented	Orient	VBN	B-VP	O
to	to	TO	B-PP	O
place	place	NN	B-NP	O
and	and	CC	I-NP	O
person	person	NN	I-NP	O
.	.	.	O	O

Year	Year	NN	B-NP	O
is	be	VBZ	B-VP	O
``	``	``	O	O
1993	1993	CD	B-NP	O
''	''	''	O	O
.	.	.	O	O

Drifting	Drift	VBG	B-VP	O
in	in	IN	B-PP	O
and	and	CC	B-PP	O
out	out	IN	B-PP	O
of	of	IN	B-PP	O
ability	ability	NN	B-NP	O
to	to	TO	B-VP	O
communicate	communicate	VB	I-VP	O
.	.	.	O	O

Perseverates	Perseverate	NNS	B-NP	O
on	on	IN	B-PP	O
answers	answer	NNS	B-NP	O
to	to	TO	B-PP	O
questions	question	NNS	B-NP	O
:	:	:	O	O
this	this	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
``	``	``	I-NP	O
hospital	hospital	NN	I-NP	O
,	,	,	O	O
hospital	hospital	NN	B-NP	O
,	,	,	O	O
hospital	hospital	NN	B-NP	O
''	''	''	O	O
,	,	,	O	O
CN	CN	NN	B-NP	B-protein
II	II	CD	I-NP	I-protein
through	through	IN	B-PP	O
XII	XII	CD	B-NP	O
intact	intact	JJ	I-NP	O
,	,	,	I-NP	O
DTR	DTR	NN	I-NP	B-protein
's	's	POS	B-NP	I-protein
2	2	CD	I-NP	I-protein
+	+	SYM	I-NP	O
symmetric	symmetric	NN	I-NP	O
in	in	IN	B-PP	O
LE	LE	NN	B-NP	O
+	+	SYM	B-NP	O
UE	UE	NN	I-NP	O
,	,	,	O	O
toes	toe	VBZ	B-VP	O
downgoing	downgoe	VBG	I-VP	O
bilaterally	bilaterally	RB	B-ADVP	O
--	--	:	O	O
--	--	:	O	O
-	-	HYPH	B-NP	O
Studies	Study	NNS	I-NP	O
:	:	:	O	O
+	+	SYM	B-NP	O
CXR	CXR	NN	B-NP	B-protein
8/19	8/19	CD	I-NP	I-protein
-	-	HYPH	B-VP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
cardiopulmonary	cardiopulmonary	JJ	I-NP	O
process	process	NN	I-NP	O
+	+	SYM	O	O
Head	Head	NNP	B-NP	O
CT	CT	NN	I-NP	B-protein
8/19	8/19	CD	I-NP	I-protein
-	-	HYPH	B-NP	O
negative	negative	JJ	I-NP	O
+	+	SYM	I-NP	O
RUQ	RUQ	NN	I-NP	B-protein
US	US	VBZ	B-VP	O
8/19	8/19	CD	B-NP	O
-	-	HYPH	I-NP	O
gallstones	gallstone	NNS	I-NP	O
,	,	,	O	O
biliary	biliary	JJ	B-NP	O
sludge	sludge	NN	I-NP	O
+	+	SYM	B-VP	O
RLE	RLE	NN	B-NP	B-protein
LENI	LENI	NN	I-NP	I-protein
8/19	8/19	CD	I-NP	I-protein
-	-	HYPH	I-NP	O
neg	neg	NN	I-NP	O
for	for	IN	B-PP	O
DVT	DVT	NN	B-NP	O
--	--	:	O	O
--	--	:	O	O
-	-	:	O	O
Hospital	Hospital	NNP	B-NP	O
Course	Course	NNP	I-NP	O
:	:	:	O	O
57	57	CD	B-NP	O
yo	yo	NN	I-NP	O
F	F	NN	I-NP	O
with	with	IN	B-PP	O
complex	complex	JJ	B-NP	O
medical	medical	JJ	I-NP	O
history	history	NN	I-NP	O
here	here	RB	B-ADVP	O
with	with	IN	B-PP	O
mental	mental	JJ	B-NP	O
status	status	NN	I-NP	O
change	change	NN	I-NP	O
likely	likely	RB	B-ADJP	O
secondary	secondary	JJ	I-ADJP	O
to	to	TO	B-PP	O
hepatic	hepatic	JJ	B-NP	O
encephalopathy	encephalopathy	NN	I-NP	O
with	with	IN	B-PP	O
some	some	DT	B-NP	O
component	component	NN	I-NP	O
of	of	IN	B-PP	O
medication-induced	medication-induced	JJ	B-NP	O
delirium	delirium	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
from	from	IN	B-PP	O
opiates	opiate	NNS	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

+	+	SYM	O	O
+	+	SYM	O	O
Mental	Mental	JJ	B-NP	O
Status	Status	NN	I-NP	O
-	-	HYPH	B-VP	O
Avoided	Avoid	VBN	I-VP	O
increasing	increase	VBG	B-NP	O
narcotics	narcotic	NNS	I-NP	O
.	.	.	O	O

Given	Give	VBN	B-NP	O
lactulose	lactulose	NN	I-NP	O
QID	QID	NNP	I-NP	O
.	.	.	O	O

Mental	Mental	JJ	B-NP	O
status	status	NN	I-NP	O
improved	improve	VBD	B-VP	O
significantly	significantly	RB	B-ADVP	O
in	in	IN	B-PP	O
first	first	JJ	B-NP	O
24	24	CD	I-NP	O
hours	hour	NNS	I-NP	O
of	of	IN	B-PP	O
hospitalization	hospitalization	NN	B-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
then	then	RB	B-ADVP	O
remained	remain	VBD	B-VP	O
at	at	IN	B-PP	O
her	her	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
mental	mental	JJ	I-NP	O
status	status	NN	I-NP	O
for	for	IN	B-PP	O
rest	rest	NN	B-NP	O
of	of	IN	B-PP	O
hospital	hospital	NN	B-NP	O
stay	stay	NN	I-NP	O
.	.	.	O	O

+	+	SYM	O	O
+	+	SYM	B-NP	O
MSK	MSK	NN	I-NP	B-protein
-	-	HYPH	O	O
Patient	Patient	NN	B-NP	O
has	have	VBZ	B-VP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
low	low	JJ	I-NP	O
back	back	JJ	I-NP	O
pain	pain	NN	I-NP	O
that	that	WDT	B-NP	O
is	be	VBZ	B-VP	O
likely	likely	RB	I-VP	O
related	relate	VBN	I-VP	O
to	to	TO	B-PP	O
bilateral	bilateral	JJ	B-NP	O
sacral	sacral	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
fractures	fracture	NNS	I-NP	O
seen	see	VBN	B-VP	O
on	on	IN	B-PP	O
MRI	MRI	NN	B-NP	B-protein
on	on	IN	B-PP	O
6/5/06	6/5/06	CD	B-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
avoided	avoid	VBD	B-VP	O
increasing	increase	VBG	I-VP	O
her	her	PRP$	B-NP	O
narcotic	narcotic	JJ	I-NP	O
dose	dose	NN	I-NP	O
for	for	IN	B-PP	O
concern	concern	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
altered	altered	JJ	I-NP	O
mental	mental	JJ	I-NP	O
status	status	NN	I-NP	O
.	.	.	O	O

Pain	Pain	NN	B-NP	B-protein
was	be	VBD	B-VP	O
controlled	control	VBN	I-VP	O
effectively	effectively	RB	B-ADVP	O
with	with	IN	B-PP	O
MSIR	MSIR	NN	B-NP	O
prn	prn	NN	I-NP	O
,	,	,	O	O
celecoxib	celecoxib	NN	B-NP	O
daily	daily	JJ	I-NP	O
prn	prn	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
should	should	MD	B-VP	O
not	not	RB	I-VP	O
increase	increase	VB	I-VP	O
to	to	TO	I-VP	O
bid	bid	VB	I-VP	O
given	give	VBN	I-VP	O
?	?	.	O	O

increase	increase	NN	B-NP	O
risk	risk	NN	I-NP	O
of	of	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	B-protein
side	side	NN	I-NP	I-protein
effects	effect	NNS	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
lidoderm	lidoderm	NN	I-NP	O
patch	patch	NN	I-NP	O
over	over	IN	B-PP	O
her	her	PRP$	B-NP	O
lower	low	JJR	I-NP	O
back	back	NN	I-NP	O
.	.	.	O	O

Other	Other	JJ	B-NP	O
NSAIDS	NSAIDS	NN	I-NP	O
were	be	VBD	B-VP	O
avoided	avoid	VBN	I-VP	O
given	give	VBN	B-PP	O
h/o	h/o	NN	B-NP	O
GI	GI	NN	I-NP	O
bleed	bleed	NN	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
is	be	VBZ	B-VP	O
scheduled	schedule	VBN	I-VP	O
to	to	TO	I-VP	O
f/u	f/u	VB	I-VP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Stayner	Stayner	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Rheumatology	Rheumatology	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
for	for	IN	B-PP	O
management	management	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
back	back	JJ	I-NP	O
pain	pain	NN	I-NP	O
and	and	CC	I-NP	O
consideration	consideration	NN	I-NP	O
of	of	IN	B-PP	O
sacroplasty	sacroplasty	NN	B-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
seen	see	VBN	I-VP	O
by	by	IN	B-PP	O
PT	PT	NN	B-NP	O
at	at	IN	B-PP	O
her	her	PRP$	B-NP	O
nursing	nursing	NN	I-NP	O
home	home	NN	I-NP	O
to	to	TO	B-VP	O
help	help	VB	I-VP	O
her	her	PRP	B-NP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
walking	walking	NN	I-NP	O
.	.	.	O	O

+	+	SYM	O	O
+	+	SYM	B-NP	O
GI/ID	GI/ID	NN	I-NP	B-protein
-	-	HYPH	O	O
Had	Have	VBD	B-VP	O
low-grade	low-grade	JJ	B-NP	O
fevers	fever	NNS	I-NP	O
overnight	overnight	RB	B-ADVP	O
on	on	IN	B-PP	O
HD	HD	NN	B-NP	B-protein
1	1	CD	I-NP	I-protein
and	and	CC	I-NP	I-protein
2	2	CD	I-NP	I-protein
.	.	.	O	O

Patient	Patient	NN	B-NP	O
had	have	VBD	B-VP	O
mild	mild	JJ	B-NP	O
RUQ	RUQ	NN	I-NP	O
tenderness	tenderness	NN	I-NP	O
which	which	WDT	B-NP	O
raised	raise	VBD	B-VP	O
a	a	DT	B-NP	O
question	question	NN	I-NP	O
of	of	IN	B-PP	O
possible	possible	JJ	B-NP	O
GI	GI	NN	I-NP	O
/	/	SYM	B-NP	O
biliary	biliary	JJ	I-NP	O
source	source	NN	I-NP	O
of	of	IN	B-PP	O
infection	infection	NN	B-NP	O
.	.	.	O	O

Blood	Blood	NN	B-NP	B-cell_line
cultures	culture	NNS	I-NP	I-cell_line
were	be	VBD	B-VP	O
positive	positive	JJ	B-ADJP	O
for	for	IN	B-PP	O
coag	coag	NN	B-NP	O
negative	negative	JJ	I-NP	O
staph	staph	NN	I-NP	O
in	in	IN	B-PP	O
2/4	2/4	CD	B-NP	O
bottles	bottle	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
Ciprofloxacin	Ciprofloxacin	NN	B-NP	O
and	and	CC	I-NP	O
Metronidazol	Metronidazol	NN	I-NP	O
starting	start	VBG	B-VP	O
on	on	IN	B-PP	O
HD	HD	NN	B-NP	B-protein
1	1	CD	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
vancomycin	vancomycin	NN	B-NP	O
until	until	IN	B-PP	O
speciation	speciation	NN	B-NP	O
of	of	IN	B-PP	O
blood	blood	NN	B-NP	O
cultures	culture	NNS	I-NP	O
.	.	.	O	O

Blood	Blood	NN	B-NP	O
cultures	culture	NNS	I-NP	O
repeated	repeat	VBN	B-VP	O
on	on	IN	B-PP	O
11/18	11/18	CD	B-NP	O
and	and	CC	I-NP	O
7/27	7/27	CD	I-NP	O
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
to	to	TO	B-PP	O
date	date	NN	B-NP	O
.	.	.	O	O

Coag	Coag	NN	B-NP	O
neg	neg	NN	I-NP	O
staph	staph	NN	I-NP	O
blood	blood	NN	I-NP	O
cultures	culture	NNS	I-NP	O
were	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
contamination	contamination	NN	B-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
has	have	VBZ	B-VP	O
remained	remain	VBN	I-VP	O
afebrile	afebrile	JJ	B-NP	O
and	and	CC	I-NP	O
abdominal	abdominal	JJ	I-NP	O
tenderness	tenderness	NN	I-NP	O
has	have	VBZ	B-VP	O
resolved	resolve	VBN	I-VP	O
over	over	IN	B-PP	O
hospital	hospital	NN	B-NP	O
stay	stay	NN	I-NP	O
.	.	.	O	O

Vancomycin	Vancomycin	NN	B-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
on	on	IN	B-PP	O
HD	HD	NN	B-NP	B-protein
3	3	CD	I-NP	I-protein
and	and	CC	O	O
Cipro	Cipro	NN	B-NP	O
and	and	CC	I-NP	O
Flagyl	Flagyl	NN	I-NP	O
were	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
with	with	IN	B-PP	O
instructions	instruction	NNS	B-NP	O
to	to	TO	B-VP	O
complete	complete	VB	I-VP	O
a	a	DT	B-NP	O
14-day	14-day	JJ	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
Cipro	Cipro	NN	B-NP	O
and	and	CC	I-NP	O
Flagyl	Flagyl	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
WBC	WBC	NNP	I-NP	O
count	count	NN	I-NP	O
and	and	CC	I-NP	O
platelets	platelet	NNS	I-NP	B-cell_type
decreased	decrease	VBD	B-VP	O
gradually	gradually	RB	B-ADVP	O
throughout	throughout	IN	B-PP	O
her	her	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
stay	stay	NN	I-NP	O
and	and	CC	O	O
were	be	VBD	B-VP	O
3.88	3.88	CD	B-NP	O
and	and	CC	I-NP	O
122	122	CD	I-NP	O
respectively	respectively	RB	B-ADVP	O
.	.	.	O	O

A	A	DT	B-NP	O
CBC	CBC	NNP	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
checked	check	VBN	I-VP	O
on	on	IN	B-PP	O
Monday	Monday	NNP	B-NP	O
6/25	6/25	CD	I-NP	O
to	to	TO	B-VP	O
make	make	VB	I-VP	O
sure	sure	JJ	B-ADJP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
not	not	RB	I-VP	O
becoming	become	VBG	I-VP	O
neutropenic	neutropenic	JJ	B-ADJP	O
or	or	CC	I-ADJP	O
thrombocytopenic	thrombocytopenic	JJ	I-ADJP	O
.	.	.	O	O

+	+	SYM	O	O
+	+	SYM	B-NP	O
Pulm	Pulm	NN	I-NP	O
-	-	HYPH	O	O
The	The	DT	B-NP	O
possibility	possibility	NN	I-NP	O
of	of	IN	B-PP	O
PE	PE	NN	B-NP	O
was	be	VBD	B-VP	O
considered	consider	VBN	I-VP	O
given	give	VBN	I-VP	O
lower	low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
swelling	swelling	NN	I-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
mental	mental	JJ	B-NP	O
status	status	NN	I-NP	O
.	.	.	O	O

Given	Give	VBN	B-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
at	at	IN	B-PP	O
her	her	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
oxygen	oxygen	NN	I-NP	O
requirement	requirement	NN	I-NP	O
and	and	CC	O	O
had	have	VBD	B-VP	O
negative	negative	JJ	B-NP	O
LENIs	LENI	NNS	I-NP	O
,	,	,	O	O
PE	PE	NN	B-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
low	low	JJ	B-NP	O
probability	probability	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
remained	remain	VBD	B-VP	O
at	at	IN	B-PP	O
her	her	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
oxygen	oxygen	NN	I-NP	O
saturation	saturation	NN	I-NP	O
-LRB-	-LRB-	HYPH	O	O
93-98	93-98	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
duration	duration	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
.	.	.	O	O

Given	Give	VBN	B-NP	O
flovent	flovent	NN	I-NP	O
for	for	IN	B-PP	O
known	known	JJ	B-NP	O
COPD	COPD	NN	I-NP	O
.	.	.	O	O

+	+	SYM	O	O
+	+	SYM	B-NP	O
CV	CV	NN	I-NP	O
-	-	HYPH	O	O
EKG	EKG	NN	B-NP	B-protein
at	at	IN	B-PP	O
admission	admission	NN	B-NP	O
was	be	VBD	B-VP	O
unchanged	unchanged	JJ	B-ADJP	O
from	from	IN	B-PP	O
previous	previous	JJ	B-NP	O
EKGs	EKG	NNS	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
's	's	POS	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
Lopressor	Lopressor	NN	B-NP	O
was	be	VBD	B-VP	O
decreased	decrease	VBN	I-VP	O
,	,	,	O	O
given	give	VBN	B-PP	O
her	her	PRP$	B-NP	O
low	low	JJ	I-NP	O
BP	BP	NN	I-NP	O
at	at	IN	B-PP	O
time	time	NN	B-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
and	and	CC	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
remained	remain	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
normal	normal	JJ	I-NP	O
range	range	NN	I-NP	O
throughout	throughout	IN	B-PP	O
her	her	PRP$	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

+	+	SYM	O	O
+	+	SYM	O	O
Endo	Endo	NNP	B-NP	O
:	:	:	O	O
MRI	MRI	NNP	B-NP	O
read	read	VBD	B-VP	O
from	from	IN	B-PP	O
3/8/06	3/8/06	CD	B-NP	O
showed	show	VBD	B-VP	O
evidence	evidence	NN	B-NP	O
of	of	IN	B-PP	O
osteoporosis	osteoporosis	NN	B-NP	O
.	.	.	O	O

Started	Start	VBN	B-NP	O
caltrate	caltrate	NN	I-NP	O
,	,	,	O	O
vit	vit	NN	B-NP	O
D.	D.	NNP	I-NP	O
Unable	Unable	NNP	I-NP	O
to	to	TO	B-VP	O
give	give	VB	I-VP	O
fosamax	fosamax	NN	B-NP	O
because	because	IN	B-PP	O
of	of	IN	I-PP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
esophageal	esophageal	JJ	B-NP	O
varices	varix	NNS	I-NP	O
.	.	.	O	O

Giving	Give	VBG	B-VP	O
zometa	zometa	SYM	O	B-DNA
x	x	NN	B-NP	I-DNA
1	1	CD	I-NP	I-DNA
.	.	.	O	O

Corrected	Correct	VBN	B-NP	O
calcium	calcium	NN	I-NP	O
was	be	VBD	B-VP	O
normal	normal	JJ	B-ADJP	O
.	.	.	O	O

Will	Will	MD	B-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
re-check	re-check	VB	I-VP	O
calcium	calcium	NN	B-NP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
week	week	NN	I-NP	O
.	.	.	O	O

+	+	SYM	O	O
+	+	SYM	B-NP	O
FEN	FEN	NN	I-NP	O
-	-	HYPH	B-NP	O
Given	Give	VBN	I-NP	O
thiamine	thiamine	NN	I-NP	O
,	,	,	O	O
folate	folate	NN	B-NP	O
,	,	,	O	O
fluids	fluid	NNS	B-NP	O
,	,	,	O	O
Is/Os	Is/O	NNS	B-NP	O
,	,	,	O	O
weights	weight	NNS	B-NP	O
.	.	.	O	O

+	+	SYM	O	O
+	+	SYM	B-NP	O
PPX	PPX	NN	I-NP	B-protein
-	-	HYPH	O	O
Lovenox	Lovenox	NN	B-NP	O
,	,	,	O	O
nexium	nexium	NN	B-NP	O
,	,	,	O	O
aspiration	aspiration	NN	B-NP	O
precautions	precaution	NNS	I-NP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
You	You	PRP	B-NP	O
are	be	VBP	B-VP	O
being	be	VBG	I-VP	O
discharged	discharge	VBN	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
to	to	TO	B-PP	O
your	your	PRP$	B-NP	O
nursing	nursing	NN	I-NP	O
home	home	NN	I-NP	O
in	in	IN	B-PP	O
Smerfortn	Smerfortn	NNP	B-NP	O
Blvd	Blvd	NNP	I-NP	O
,	,	,	O	O
Stin	Stin	NNP	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
few	few	JJ	I-NP	O
changes	change	NNS	I-NP	O
in	in	IN	B-PP	O
your	your	PRP$	B-NP	O
medications	medication	NNS	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
changed	change	VBN	I-VP	O
your	your	PRP$	B-NP	O
pain	pain	NN	I-NP	O
medication	medication	NN	I-NP	O
to	to	TO	B-VP	O
MSIR	MSIR	NN	I-VP	B-protein
every	every	DT	B-NP	O
4	4	CD	I-NP	O
hr	hr	NN	I-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
,	,	,	O	O
celebrex	celebrex	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
lidoderm	lidoderm	NN	B-NP	O
patch	patch	NN	I-NP	O
.	.	.	O	O

Please	Please	VB	B-VP	O
call	call	VB	I-VP	O
your	your	PRP$	B-NP	O
doctor	doctor	NN	I-NP	O
if	if	IN	B-SBAR	O
you	you	PRP	B-NP	O
are	be	VBP	B-VP	O
feeling	feel	VBG	I-VP	O
that	that	IN	B-SBAR	O
your	your	PRP$	B-NP	O
thinking	thinking	NN	I-NP	O
is	be	VBZ	B-VP	O
not	not	RB	O	O
clear	clear	JJ	B-ADJP	O
or	or	CC	O	O
if	if	IN	B-SBAR	O
you	you	PRP	B-NP	O
start	start	VBP	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
fevers	fever	NNS	B-NP	O
.	.	.	O	O

And	And	CC	O	O
please	please	VB	B-VP	O
return	return	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
department	department	NN	I-NP	O
if	if	IN	B-SBAR	O
you	you	PRP	B-NP	O
are	be	VBP	B-VP	O
having	have	VBG	I-VP	O
increased	increase	VBN	B-NP	O
abdominal	abdominal	JJ	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
difficulty	difficulty	NN	B-NP	O
breathing	breathing	NN	I-NP	O
,	,	,	O	O
or	or	CC	O	O
other	other	JJ	B-NP	O
concerning	concern	VBG	I-NP	O
symptoms	symptom	NNS	I-NP	O
.	.	.	O	O

You	You	PRP	B-NP	B-protein
should	should	MD	B-VP	O
have	have	VB	I-VP	O
your	your	PRP$	B-NP	O
blood	blood	NN	I-NP	O
counts	count	NNS	I-NP	O
checked	check	VBD	B-VP	O
on	on	IN	B-PP	O
Monday	Monday	NNP	B-NP	O
and	and	CC	O	O
your	your	PRP$	B-NP	O
calcium	calcium	NN	I-NP	O
checked	check	VBD	B-VP	O
next	next	JJ	B-NP	O
week	week	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
Follow	Follow	VB	B-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Vargas	Vargas	NNP	I-NP	O
at	at	IN	B-PP	O
next	next	JJ	B-NP	O
available	available	JJ	I-NP	O
appointment	appointment	NN	I-NP	O
.	.	.	O	O

Please	Please	NNP	B-NP	O
call	call	NN	I-NP	O
Dr.	Dr.	NNP	I-NP	O
Megeath	Megeath	NNP	I-NP	O
office	office	NN	I-NP	O
to	to	TO	B-PP	O
schedule	schedule	NN	B-NP	O
.	.	.	O	O

Follow	Follow	VB	B-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Blandin	Blandin	NNP	I-NP	O
and	and	CC	O	O
Dr.	Dr.	NNP	B-NP	O
Pfleider	Pfleider	NNP	I-NP	O
as	as	IN	B-SBAR	O
scheduled	schedule	VBN	B-VP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
seen	see	VBN	I-VP	O
by	by	IN	B-PP	O
physical	physical	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
at	at	IN	B-PP	O
her	her	PRP$	B-NP	O
nursing	nursing	NN	I-NP	O
home	home	NN	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
should	should	MD	B-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
CBC	CBC	NN	I-NP	B-protein
drawn	draw	VBN	B-VP	O
on	on	IN	B-PP	O
Monday	Monday	NNP	B-NP	O
6/25	6/25	CD	I-NP	O
to	to	TO	B-VP	O
check	check	VB	I-VP	O
her	her	PRP$	B-NP	O
white	white	JJ	I-NP	O
count	count	NN	I-NP	O
and	and	CC	I-NP	O
platements	platement	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
trending	trend	VBG	I-VP	O
down	down	RB	B-ADVP	O
slowly	slowly	RB	B-ADVP	O
throughout	throughout	IN	B-PP	O
her	her	PRP$	B-NP	O
admission	admission	NN	I-NP	O
and	and	CC	O	O
recheck	recheck	VB	B-VP	O
calcium	calcium	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
corrected	correct	VBN	B-VP	O
for	for	IN	B-PP	O
albumin	albumin	NN	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
in	in	IN	B-PP	O
one	one	CD	B-NP	O
week	week	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
MIAH	MIAH	NNP	B-NP	O
,	,	,	O	O
RUDY	RUDY	NNP	B-NP	O
E.	E.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
RI25	RI25	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10/28/06	10/28/06	CD	I-NP	O
@	@	SYM	B-NP	O
11	11	CD	I-NP	O
******	******	SYM	I-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

